JPMorgan Chase & Co’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-58,683
| Closed | -$171K | – | 6137 |
|
|
2021
Q3 | $171K | Sell |
58,683
-75,950
| -56% | -$221K | ﹤0.01% | 4486 |
|
|
2021
Q2 | $470K | Buy |
134,633
+60,484
| +82% | +$211K | ﹤0.01% | 4034 |
|
|
2021
Q1 | $254K | Buy |
74,149
+17,430
| +31% | +$59.7K | ﹤0.01% | 4367 |
|
|
2020
Q4 | $1.09M | Sell |
56,719
-5,952
| -9% | -$114K | ﹤0.01% | 3330 |
|
|
2020
Q3 | $909K | Buy |
62,671
+54,963
| +713% | +$797K | ﹤0.01% | 3139 |
|
|
2020
Q2 | $326K | Sell |
7,708
-19,879
| -72% | -$841K | ﹤0.01% | 3479 |
|
|
2020
Q1 | $762K | Buy |
27,587
+15,732
| +133% | +$435K | ﹤0.01% | 3102 |
|
|
2019
Q4 | $385K | Buy |
11,855
+8,011
| +208% | +$260K | ﹤0.01% | 3543 |
|
|
2019
Q3 | $100K | Sell |
3,844
-10,249
| -73% | -$267K | ﹤0.01% | 3998 |
|
|
2019
Q2 | $495K | Sell |
14,093
-25,965
| -65% | -$912K | ﹤0.01% | 3377 |
|
|
2019
Q1 | $886K | Buy |
40,058
+25,641
| +178% | +$567K | ﹤0.01% | 3089 |
|
|
2018
Q4 | $203K | Buy |
14,417
+4,007
| +38% | +$56.4K | ﹤0.01% | 3808 |
|
|
2018
Q3 | $202K | Buy |
10,410
+2,302
| +28% | +$44.7K | ﹤0.01% | 3866 |
|
|
2018
Q2 | $179K | Buy |
8,108
+6,746
| +495% | +$149K | ﹤0.01% | 3864 |
|
|
2018
Q1 | $29K | Buy |
+1,362
| New | +$29K | ﹤0.01% | 4318 |
|